Artesunate Versus Quinine: Keeping Our Options Open
- PMID: 31044240
- PMCID: PMC7346886
- DOI: 10.1093/cid/ciz335
Artesunate Versus Quinine: Keeping Our Options Open
Keywords: Plasmodium falciparum; artesunate; quinine; severe malaria.
Comment on
-
Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France.Clin Infect Dis. 2020 Jan 2;70(2):280-287. doi: 10.1093/cid/ciz206. Clin Infect Dis. 2020. PMID: 30874798
References
-
- El Ket et al. Clin Infect Dis.
-
- Alpern JD, Song J, Stauffer WM. Essential medicines in the United States–why access is diminishing. N Engl J Med 2016; 374:1904–7. - PubMed
-
- Global Health Division of Parasitic Diseases and Malaria. Availability of intravenous artesunate for treatment of severe malaria in the United States Available at: https://www.cdc.gov/malaria/diagnosis_treatment/artesunate.html. Accessed 15 April 2019.
-
- Cao XT, Bethell DB, Pham TP, . et al. Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria. Trans R Soc Trop Med Hyg 1997; 91:335–42. - PubMed
-
- Eltahir HG, Omer AA, Mohamed AA, Adam I. Comparison of artesunate and quinine in the treatment of Sudanese children with severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2010; 104:684–6. - PubMed
